Finance China’s mAb and ADC licensing was 3xUS’s in 2024 — will trade tensions slow it?May 20, 20250 China’s biopharmaceutical sector noticed an increase in oncology drug licensing offers in 2024, significantly for monoclonal antibodies (mAbs) and antibody-drug…
